Table 4.
Univariate and multivariate analyses of overall survival in OS patients.
| Factors | Univariate | Multivariate | ||||
|---|---|---|---|---|---|---|
| Hazard ratio | 95% CI | P | Hazard ratio | 95% CI | P | |
| Age, years (≤20/>20) | 1.017 | (0.954–1.057) | 0.479 | 1.177 | (0.671–1.571) | 0.759 |
| Gender (male/female) | 1.134 | (0.718–2.271) | 0.379 | 1.537 | (0.519–1.871) | 0.442 |
| Tumor stage (I, II/III) | 6.771 | (2.177–13.079) | <0.001 | 6.147 | (2.274–11.34) | <0.001 |
| Distant metastasis (yes/no) | 2.977 | (1.374–5.127) | 0.002 | 1.871 | (0.757–2.622) | 0.179 |
| Differentiation status (high/low) | 1.297 | (0.674–2.774) | 0.057 | 1.087 | (0.633–1.997) | 0.217 |
| B7-H4 expression (high/low) | 5.257 | (2.224–9.274) | <0.001 | 3.147 | (1.32–7.377) | 0.004 |
| sB7-H4 levels (high/low)* | 4.371 | (2.971–8.374) | 0.001 | 2.022 | (1.547–4.607) | 0.041 |
*92.28 ng/mL as the cutoff value to divide OS patients into groups with high (n = 36) and low (n = 50) sB7-H4 levels.